Wyniki wyszukiwania

1

Elastase, alpha1-proteinase inhibitor, and interleukin-8 in children and young adults with end-stage kidney disease undergoing continuous ambulatory peritoneal dialysis

100%

Polanska B., Augustyniak D., Makulska I., Niemczuk M., Jankowski A., Zwolinska D.

Archivum Immunologiae et Therapiae Experimentalis

|

2014

|

tom 62

|

nr 3

2

Prevalence of sleep apnea syndrome in hemodialyzed patients with end-stage renal disease

84%

Miskowiec I., Klawe J. J., Tafil-Klawe M., Jeske K., Laudencka A., Bielicka B., Manitius J., Zlomanczuk P.

Journal of Physiology and Pharmacology. Supplement

|

2006

|

tom 57

|

nr 4

207-211

The majority of hemodialyzed patients suffer from sleep disturbances. In the present study the prelevence of sleep apnea syndrome in hemodialyzed patients with end-stage renal disease (ESRD-patients) was investigated by the survey, Epworth Sleepiness Scale (ESS), and polysomnography (PSG). Sixty-one patients: 24 women and 37 men were involved in the study. All subjects participated in the first part of the study consisting of the survey and ESS. The second and third parts consisted of nighttime PSG, performed the night after hemodialysis (17 patients) and between hemodialyses (11 patients). Eleven out of the 61 patients had the symptoms of sleep apnea and heavy daily sleepiness. Eleven subjects were involved in the double PSG study: after and between hemodialyses. Obstrucive sleep apnea was found in 7 of those patients during both nights analyzed. Our results confirm the occurrence of sleep disorders in ESRD-patients. Hemodialysis does not change the prevalence of obstructive sleep apnea in chronic renal disease.

3

The PD-1/PD-L1 inhibitory pathway is altered in primary glomerulonephritides

67%

Grywalska E., Smarz-Widelska I., Krasowska-Zajac E., Korona-Glowniak I., Zaluska-Patel K., Mielnik M., Podgajna M., Malm A., Rolinski J., Zaluska W.

Archivum Immunologiae et Therapiae Experimentalis

|

2018

|

tom 66

|

nr 2

4

Influence of megestrol acetate on nutrition and inflammation in dialysis patients - preliminary results

67%

Golebiewska J., Lichodziejewska-Niemierko M., Aleksandrowicz E., Majkowicz M., Lysiak-Szydlowska W., Rutkowski B.

Acta Biochimica Polonica

|

2009

|

tom 56

|

nr 4

733-737

Malnutrition is a common clinical problem in dialysis patients. So far the management of malnutrition in this population has not been fully successful. The aim of the study was to evaluate the efficacy and safety of use of megestrol acetate suspension in malnourished dialysis patients. Twenty-six hypoalbuminemic (albumin ≤ 3.8 g/dl) dialysis patients took 160 mg of megestrol acetate daily for a period of two months. Anthropometry (dry weight, body mass index) and biochemical measurements of nutrition (serum albumin, triglycerides, total cholesterol) and inflammation (hsCRP, IL-1β, IL-6) were performed on a monthly basis. The treatment led to a statistically significant increase (P < 0.05) in anthropometry and albumin concentration, with no statistically significant changes in total cholesterol, triglycerides and indices of inflammation. Side effects included overhydration, diarrhoea and hyperglycaemia. Thus, megestrol acetate may be an effective therapeutic agent in improving the nutritional status of carefully selected dialysis patients, while it might not mitigate inflammation. Because of the prevalent side effects it must be monitored closely.

5

Decorin deficiency in diabetic mice: Aggravation of nephropathy due to overexpression of profibrotic factors, enhanced apoptosis and mononuclear cell infiltration

59%

Merline R., Lazaroski S., Babelova A., Tsalastra-Greul W., Pfeilschifter J., Schluter K. D., Gunther A., Iozzo R. V., Schaefer R. M., Schaefer L.

Journal of Physiology and Pharmacology. Supplement

|

2009

|

tom 60

|

nr 4

Ograniczanie wyników

Elastase, alpha1-proteinase inhibitor, and interleukin-8 in children and young adults with end-stage kidney disease undergoing continuous ambulatory peritoneal dialysis

Prevalence of sleep apnea syndrome in hemodialyzed patients with end-stage renal disease

The PD-1/PD-L1 inhibitory pathway is altered in primary glomerulonephritides

Influence of megestrol acetate on nutrition and inflammation in dialysis patients - preliminary results

Decorin deficiency in diabetic mice: Aggravation of nephropathy due to overexpression of profibrotic factors, enhanced apoptosis and mononuclear cell infiltration